EML vs JAZZ · P/E 11, rev $121.5M vs P/E 1988, rev $2.28B
Eastern Co (EML) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Eastern Co (EML) is a tools & accessories company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported EML revenue for 2026-07-04 was $121.5M. Net income was $6.3M. EML currently screens at market cap $149.4M and trailing P/E 11.4.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
EML currently screens at market cap $149.4M and trailing P/E 11.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the EML and JAZZ stock pages for the full models.
Not investment advice.